SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-127418
Filing Date
2023-04-28
Accepted
2023-04-28 16:51:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d480925ddefa14a.htm DEFA14A 30068
2 GRAPHIC g480925gra001.jpg GRAPHIC 9580
3 GRAPHIC g480925gra002.jpg GRAPHIC 8511
4 GRAPHIC g480925gra003.jpg GRAPHIC 8502
5 GRAPHIC g480925gra004.jpg GRAPHIC 8149
6 GRAPHIC g480925gra005.jpg GRAPHIC 8159
7 GRAPHIC g480925gra006.jpg GRAPHIC 8461
  Complete submission text file 0001193125-23-127418.txt   70363
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39248 | Film No.: 23867674
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine